FLGT
Ticker
Fulgent Genetics Inc
Company
Diagnostics
Industry
Healthcare
Sector
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
649.3%90.9%2.5%14.0%52.3%1196.5%135.4%-37.6%-53.3%-2.0% 13.6%
Revenue Growth QoQ
Gross Margin
26.8%47.1%63.2%54.3%49.9%56.6%78.7%78.3%59.3%36.1%37.8% 41.2%
EBITDA Margin
-62.1%-46.3%11.4%-9.4%-13.6%5.2%69.5%69.2%34.1%-58.6%-17.3% -14.8%
Operating Margin
-77.5%-52.3%5.0%-18.6%-23.7%-1.3%68.8%68.1%28.8%-67.6%-26.1% -22.5%
Profit Margin
-335.1%-86.8%-29.3%-13.4%-26.3%-1.3%50.8%51.1%23.2%-58.0%-15.1% -13.6%
FCF / EBITDA
645.8%69.2%29.5%89.2%103.1%258.2%36.0%74.9%111.2%-2.8%39.3% 42.4%